Delivery Order SPE2DB22D9316-SPE2DB24FYN25
Award Date 1/22/24
Potential Completion Date 2/12/24
Potential Value $2.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of VELCADE 3.5 mg vials, with a potential value of $10,290.87. The contract has a completion date of January 11, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a wide range of pharmaceutical and medical products to the federal government, primarily the...
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 3.5 mg vials of the pharmaceutical drug VELCADE. The $13,988.64 contract has a completion date of March 7, 2024 and is not set aside for any special designation. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds a larger indefinite delivery contract with DLA, valued up to $4,999,999 through 2025, to deliver a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,758.60 delivery order is for the supply of VELCADE 3.5 MG VIALS, a specialty oncology medication. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,988.64 firm fixed-price contract is for the delivery of VELCADE 3.5 MG VIALS to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 3.5 mg vials of the pharmaceutical product Velcade. The $11,657.20 contract has a completion date of February 5, 2024. This delivery order is part of a larger indefinite delivery contract vehicle between DMS Pharmaceutical Group and DLA Troop Support Medical to supply a variety of pharmaceutical items and medical products to support military...
- This firm fixed-price delivery order, valued at $34,971.60, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of VELCADE 3.5 MG VIALS to the Defense Logistics Agency (DLA), Medical Supply Chain division, under the SPE2DX24F6XFU indefinite delivery contract. DMS Pharmaceutical Group holds a larger indefinite delivery contract (SPE2DB) with the DLA, valued up to $499,999,999, to provide a comprehensive range...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is part of a larger single-award indefinite delivery contract (IDC) with the DLA worth up to $499,999,999, which runs through December 31, 2025. The current delivery order is for $11,657.20 and is for the supply of 3.5 mg vials of the drug VELCADE. This order is placed under a firm fixed-price...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,151.45 contract is for the delivery of VELCADE 3.5 MG VIALS, a specialized oncology medication, with a period of performance through December 22, 2023. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $13,744.20, is for the provision of Velcade 3.5 mg vials, with a period of performance ending on November 24, 2021. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, on March 27, 2024. The contract, valued at $11,657.20, is for the delivery of 3.5 mg vials of the cancer medication VELCADE. The order has an ultimate completion date of April 17, 2024. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, SPE2DB, that DMS Pharmaceutical Group holds with the DLA, valued at up to...